A Novel CMY Variant Confers Transferable High-Level Resistance to Ceftazidime-Avibactam in Multidrug-Resistant Escherichia coli

Here, our objective was to explore the molecular mechanism underlying ceftazidime-avibactam resistance in a novel CMY-178 variant produced by the clinical Escherichia coli strain AR13438. The antibiotic susceptibility of the clinical isolate, its transconjugants, and its transformants harboring tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Junxin, Wang, Weiping, Liang, Min, Yu, Qian, Cai, Shiqi, Lei, Tailong, Jiang, Yan, Du, Xiaoxing, Zhou, Zhihui, Yu, Yunsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100771/
https://www.ncbi.nlm.nih.gov/pubmed/36786629
http://dx.doi.org/10.1128/spectrum.03349-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100771/
https://www.ncbi.nlm.nih.gov/pubmed/36786629
http://dx.doi.org/10.1128/spectrum.03349-22

Ejemplares similares